{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_641", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "0 IU doses could be as much \nas US$ 100 per woman. Additional costs will include \nscreening for blood typing in settings where Rh blood \ntests are not currently performed.\nEquity\nThe contribution of RhD alloimmunization to \nperinatal morbidity and mortality in various LMIC \nsettings is uncertain and it is not known whether \nantenatal anti-D for non-sensitized Rh-negative \nwomen will impact on equity.\nAcceptability\nAnti-D immunoglobulin is derived from human \nplasma and is administered by injecti"}